Researchers in the US have
said that testing 10 lipids in blood
predicted phenoconversion to
amnestic mild cognitive impairment
or Alzheimer’s Disease (AD) within
two to three years with 90%
accuracy.
The five year study, published in
Nature Medicine, looked at blood
sampled from 525 people over the
age of 70, the BBC reported.
The study compared 53
participants who developed AD
or mild cognitive impairment with
53 who stayed mentally agile and
found lipid level differences, the
publication reported.
To read the story, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Mar 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.